- Home
- STTK vs CVU Comparison
STTK vs CVU Comparison
Compare STTK & CVU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- CVU
- Stock Information
- Founded
- STTK 2016
- CVU 1980
- Country
- STTK United States
- CVU United States
- Employees
- STTK N/A
- CVU N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- CVU Military/Government/Technical
- Sector
- STTK Health Care
- CVU Industrials
- Exchange
- STTK Nasdaq
- CVU Nasdaq
- Market Cap
- STTK 54.4M
- CVU 48.5M
- IPO Year
- STTK 2020
- CVU N/A
- Fundamental
- Price
- STTK $1.08
- CVU $3.81
- Analyst Decision
- STTK Hold
- CVU
- Analyst Count
- STTK 3
- CVU 0
- Target Price
- STTK $2.00
- CVU N/A
- AVG Volume (30 Days)
- STTK 329.4K
- CVU 39.0K
- Earning Date
- STTK 11-14-2024
- CVU 11-13-2024
- Dividend Yield
- STTK N/A
- CVU N/A
- EPS Growth
- STTK N/A
- CVU 86.98
- EPS
- STTK N/A
- CVU 1.37
- Revenue
- STTK $6,435,000.00
- CVU $82,814,085.00
- Revenue This Year
- STTK $313.04
- CVU N/A
- Revenue Next Year
- STTK N/A
- CVU N/A
- P/E Ratio
- STTK N/A
- CVU $2.88
- Revenue Growth
- STTK 382.75
- CVU N/A
- 52 Week Low
- STTK $0.94
- CVU $2.16
- 52 Week High
- STTK $11.76
- CVU $4.07
- Technical
- Relative Strength Index (RSI)
- STTK 40.71
- CVU 57.05
- Support Level
- STTK $1.07
- CVU $3.60
- Resistance Level
- STTK $1.38
- CVU $3.94
- Average True Range (ATR)
- STTK 0.13
- CVU 0.18
- MACD
- STTK 0.01
- CVU 0.01
- Stochastic Oscillator
- STTK 9.09
- CVU 51.85
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About CVU CPI Aerostructures Inc.
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.